Literature DB >> 14705152

Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa.

Nicole C Barbarich1, Claire W McConaha, Katherine A Halmi, Kelly Gendall, Suzanne R Sunday, Jill Gaskill, Maria La Via, Guido K Frank, Sarah Brooks, Katherine H Plotnicov, Walter H Kaye.   

Abstract

OBJECTIVE: Selective serotonin reuptake inhibitor (SSRI) medication does not appear to be effective in ill, malnourished anorexia nervosa (AN) patients. However, it may be effective in preventing relapse after weight restoration. The purpose of this study was to determine whether nutritional supplements could potentiate the effects of fluoxetine in underweight AN subjects.
METHOD: Twenty-six subjects with AN participated in a trial of fluoxetine. In a double-blind, placebo-controlled manner, subjects received either nutritional supplements or a nutritional placebo. The nutritional supplement included tryptophan (the precursor of serotonin), vitamins, minerals, and essential fatty acids believed to influence serotonin pathway function.
RESULTS: There was no significant difference in weight gain between subjects treated with fluoxetine plus nutritional supplements versus fluoxetine plus a nutritional placebo. Moreover, there were no significant differences between groups on mean changes in anxiety or obsessive and compulsive symptoms. DISCUSSION: The results of this study suggest that supplement strategies are not a substitute for adequate nutrition and are ineffective in increasing the efficacy of fluoxetine in underweight AN subjects. Copyright 2003 by Wiley Periodicals, Inc. Int J Eat Disord 35: 10-15, 2004.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14705152     DOI: 10.1002/eat.10235

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  19 in total

1.  The multimodal treatment of eating disorders.

Authors:  Katherine A Halmi
Journal:  World Psychiatry       Date:  2005-06       Impact factor: 49.548

Review 2.  The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects.

Authors:  Guido K W Frank; Megan E Shott
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

Review 3.  The psychopharmacotherapy of anorexia nervosa: clinical, neuroendocrine and metabolic aspects.

Authors:  G Abbate Daga; L Gianotti; V Mondelli; R Quartesan; S Fassino
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

4.  Food restriction and streptozotocin differentially modify sensitivity to the hypothermic effects of direct- and indirect-acting serotonin receptor agonists in rats.

Authors:  Jun-Xu Li; Wouter Koek; Charles P France
Journal:  Eur J Pharmacol       Date:  2009-04-18       Impact factor: 4.432

5.  Eating disorders: National Institute of Mental Health's perspective.

Authors:  Mark Chavez; Thomas R Insel
Journal:  Am Psychol       Date:  2007-04

6.  A review of medication use for children and adolescents with eating disorders.

Authors:  Jennifer Couturier; James Lock
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2007-11

Review 7.  (N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders.

Authors:  Pedro Luis Prior; José Carlos Fernandes Galduróz
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

8.  Reduced effectiveness of escitalopram in the forced swimming test is associated with increased serotonin clearance rate in food-restricted rats.

Authors:  Charles P France; Jun-Xu Li; William A Owens; Wouter Koek; Glenn M Toney; Lynette C Daws
Journal:  Int J Neuropsychopharmacol       Date:  2009-05-07       Impact factor: 5.176

9.  A pilot randomized controlled trial of omega-3 fatty acid supplementation for the treatment of anxiety in adolescents with anorexia nervosa.

Authors:  Brittny E Manos; Terrill D Bravender; Tondi M Harrison; Hannah L H Lange; Casey B Cottrill; Mahmoud Abdel-Rasoul; Andrea E Bonny
Journal:  Int J Eat Disord       Date:  2018-10-26       Impact factor: 4.861

Review 10.  Pharmacotherapeutic strategies for the treatment of anorexia nervosa - too much for one drug?

Authors:  Guido K W Frank
Journal:  Expert Opin Pharmacother       Date:  2020-04-13       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.